Recent studies on tauopathy animal models suggest that the concomitant expression of the endogenous murine tau delays the pathological accumulation of human tau, and interferes with the disease progression. To elucidate the role of endogenous murine tau in a model with both plaques and tangles, we developed a novel transgenic mouse model by crossing 3xTg-AD with mtauKO mice (referred to as 3xTg-AD/mtauKO mice). Therefore, this new model allows us to determine the pathological consequences of the murine tau. Here, we show that 3xTg-AD/mtauKO mice have lower tau loads in both soluble and insoluble fractions, and lower tau hyperphosphorylation level in the soluble fraction relative to 3xTg-AD mice. In the 3xTg-AD model endogenous mouse tau is hyperphosphorylated and significantly co-aggregates with human tau. Despite the deletion of the endogenous tau gene in 3xTg-AD/mtauKO mice, cognitive dysfunction was equivalent to 3xTg-AD mice, as there was no additional impairment on a spatial memory task, and thus despite increased tau phosphorylation, accumulation and NFTs in 3xTg-AD mice no further effects on cognition are seen. These findings provide better understanding about the role of endogenous tau to Alzheimer's disease (AD) pathology and for developing new AD models.
Introduction
Alzheimer's disease (AD) is a progressive neurological disorder associated with senile dementia among elderly populations. The afflicted brain contains several pathological hallmarks, including extracellular Aβ-amyloid plaques, intraneuronal neurofibrillary tau tangles (NFTs) and extensive neuronal and synaptic loss (Querfurth and LaFerla, 2010) . It is believed that these hallmark pathologies are related, with overwhelming evidence showing that pathological conformations of Aβ can trigger the abnormal hyperphosphorylation of tau and lead to NFTs (Gotz et al., 2001; Lewis et al., 2001; Oddo et al., 2004 Oddo et al., , 2008 Tseng et al., 2008) . Additionally, recent animal studies have shown that tau protein is necessary for Aβ to cause memory impairments, thus cementing the detrimental relationship between the two pathological proteins (Brion et al., 1999; Medeiros et al., 2011; Roberson et al., 2007; Shipton et al., 2011) . Hence, these studies suggest that tau is an important enactor of Aβ-induced cognitive decline and neurodegeneration.
Tau is a neuron-specific cytoskeletal protein that is directly involved in maintaining the integrity, stability and dynamics of microtubules (Medeiros et al., 2011; Terwel et al., 2002) . Moreover, there is recent evidence suggesting that tau exerts an important role in signal transduction, neurite outgrowth and stabilization during brain development and interaction with actin cytoskeleton (Denk and Wade-Martins, 2009; Hernandez and Avila, 2007) . Tau exists as an unfolded form and mainly associated to microtubules (MT) in the brain; however, in several neurodegenerative disorders, tau is highly phosphorylated and becomes characteristically insoluble. This insolubility leads to aggregation of NFT in selected brain regions. These pathological changes are observed in AD and other human tauopathies such as Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), argyrophilic grain disease and frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) (Denk and Wade-Martins, 2009; Hernandez and Avila, 2007) .
Several transgenic lines have been created that model human tauopathies, via overexpression of FTD-associated mutant tau transgenes in neurons (Medeiros et al., 2011) . These models show increased hyperphosphorylated tau, most of them eventually form NFTs, and show neurodegeneration. It is important to note that these transgenic lines contain endogenous murine tau, in addition to the mutant human tau produced by the transgenes. Several studies have shown that the presence of this endogenous murine tau delays the pathological accumulation of human tau (Brion et al., 1999; Duff et al., 2000; Gotz et al., 1995; Higuchi et al., 2002; Ishihara et al., 1999 Ishihara et al., , 2001 Probst et al., 2000) . In other words, when the endogenous murine tau is removed from transgenic tau mice, the onset and the progression of AD-like NFT and paired helical filament (PHF) aggregates are accelerated (Ando et al., 2011; Neurobiology of Disease 62 (2014) 
